Order Article Reprints

Lebenthal Y, Brener A, Hershkovitz E, Shehadeh N, Shalitin S, Lewis EC, Elias D, Haim A, Barash G, Loewenthal N, et al. A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia^®) in the Treatment of Recent-Onset Type 1 Diabetes. International Journal of Molecular Sciences. 2019; 20(23):6032. https://doi.org/10.3390/ijms20236032

Lebenthal, Yael, Avivit Brener, Eli Hershkovitz, Naim Shehadeh, Shlomit Shalitin, Eli C. Lewis, Dana Elias, Alon Haim, Galia Barash, Neta Loewenthal, and et al. 2019. "A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia^®) in the Treatment of Recent-Onset Type 1 Diabetes" International Journal of Molecular Sciences 20, no. 23: 6032. https://doi.org/10.3390/ijms20236032

Lebenthal, Y., Brener, A., Hershkovitz, E., Shehadeh, N., Shalitin, S., Lewis, E. C., Elias, D., Haim, A., Barash, G., Loewenthal, N., Zuckerman-Levin, N., Stein, M., Tov, N., & Rachmiel, M. (2019). A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia^®) in the Treatment of Recent-Onset Type 1 Diabetes. International Journal of Molecular Sciences, 20(23), 6032. https://doi.org/10.3390/ijms20236032